|
1
|
Li Q, Zeng K, Chen Q, Han C, Wang X, Li B,
Miao J, Zheng B, Liu J, Yuan X and Liu B: Atractylenolide I
inhibits angiogenesis and reverses sunitinib resistance in clear
cell renal cell carcinoma through ATP6V0D2-mediated autophagic
degradation of EPAS1/HIF2α. Autophagy. 21:619–638. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cao J, Luo X, Zhou Z, Duan Y, Xiao L, Sun
X, Shang Q, Gong X, Hou Z, Kong D and He B: Comparison of
diffusion-weighted imaging mono-exponential mode with diffusion
kurtosis imaging for predicting pathological grades of clear cell
renal cell carcinoma. Eur J Radiol. 130:1091952020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fan X, Fu F, Liang R, Xue E, Zhang H, Zhu
Y and Ye Q: Associations between contrast-enhanced ultrasound
features and WHO/ISUP grade of clear cell renal cell carcinoma: A
retrospective study. Int Urol Nephrol. 56:1157–1164. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Q, Liu YJ, Dong D, Bai X, Huang QB, Guo
AT, Ye HY, Tian J and Wang HY: Multiparametric MRI radiomic model
for preoperative predicting WHO/ISUP nuclear grade of clear cell
renal cell carcinoma. J Magn Reson Imaging. 52:1557–1566. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi JW, Hu R, Zhao Y, Purkayastha S, Wu
J, McGirr AJ, Stavropoulos SW, Silva AC, Soulen MC, Palmer MB, et
al: Preoperative prediction of the stage, size, grade, and necrosis
score in clear cell renal cell carcinoma using MRI-based radiomics.
Abdom Radiol (NY). 46:2656–2664. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rizzo A, Racca M, Dall'Armellina S,
Rescigno P, Banna GL, Albano D, Dondi F, Bertagna F, Annunziata S
and Treglia G: The emerging role of PET/CT with PSMA-Targeting
radiopharmaceuticals in clear cell renal cancer: An updated
systematic review. Cancers (Basel). 15:3552023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen XY, Zhang Y, Chen YX, Huang ZQ, Xia
XY, Yan YX, Xu MP, Chen W, Wang XL and Chen QL: MRI-based grading
of clear cell renal cell carcinoma using a machine learning
classifier. Front Oncol. 11:7086552021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yasaka K, Kamagata K, Ogawa T, Hatano T,
Takeshige-Amano H, Ogaki K, Andica C, Akai H, Kunimatsu A, Uchida
W, et al: Parkinson's disease: Deep learning with a
parameter-weighted structural connectome matrix for diagnosis and
neural circuit disorder investigation. Neuroradiology.
63:1451–1462. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng Q, Ren A, Xu X, Meng Z, Feng X,
Pylypenko D, Dou W and Yu D: Application of DKI and IVIM imaging in
evaluating histologic grades and clinical stages of clear cell
renal cell carcinoma. Front Oncol. 13:12039222023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosenkrantz AB, Padhani AR, Chenevert TL,
Koh DM, De Keyzer F, Taouli B and Le Bihan D: Body diffusion
kurtosis imaging: Basic principles, applications, and
considerations for clinical practice. J Magn Reson Imaging.
42:1190–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu Q, Zhu W, Wu J, Chen W, Ye J and Ling
J: Comparative study of conventional diffusion-weighted imaging and
introvoxel incoherent motion in assessment of pathological grade of
clear cell renal cell carcinoma. Br J Radiol. 95:202104852022.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou J, Ye J, Zhu W, Wu J, Chen W, Chen R
and Zhu Q: Diffusion-weighted and diffusion kurtosis imaging
analysis of microstructural differences in clear cell renal cell
carcinoma: A comparative study. Br J Radiol. 96:202301462023.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye J, Xu Q, Wang SA, Zheng J and Dou WQ:
Quantitative evaluation of intravoxel incoherent motion and
diffusion kurtosis imaging in assessment of pathological grade of
clear cell renal cell carcinoma. Acad Radiol. 27:e176–e182. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu G, Zhao Z, Yao Q, Kong W, Xu J, Zhang
J, Liu G and Dai Y: The study of clear cell renal cell carcinoma
with MR diffusion kurtosis tensor imaging and its histopathologic
correlation. Acad Radiol. 25:430–438. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meyer HJ, Martin M and Denecke T: DWI of
the Breast-possibilities and limitations. Rofo. 194:966–974. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, He K, Yuan G, Yong X, Meng X, Feng
C, Zhang Y, Kamel IR and Li Z: WHO/ISUP grade and pathological T
stage of clear cell renal cell carcinoma: Value of ZOOMit diffusion
kurtosis imaging and chemical exchange saturation transfer imaging.
Eur Radiol. 33:4429–4439. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duan Z, Tao J, Liu W, Liu Y, Fang S, Yang
Y, Liu X, Deng X, Song Y and Wang S: Correlation of IVIM/DKI
parameters with hypoxia biomarkers in fibrosarcoma murine models:
Direct control of MRI and pathological sections. Acad Radiol.
31:1014–1023. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song Q, Dong W, Tian S, Xie L, Chen L, Wei
Q and Liu A: Diffusion kurtosis imaging with multiple quantitative
parameters for predicting microsatellite instability status of
endometrial carcinoma. Abdom Radiol (NY). 48:3746–3756. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Litvin AA, Burkin DA, Kropinov AA and
Paramzin FN: Radiomics and digital image texture analysis in
oncology (review). Sovrem Tehnologii Med. 13:972021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li D, Hu J, Zhang L, Li L, Yin Q, Shi J,
Guo H, Zhang Y and Zhuang P: Deep learning and machine
intelligence: New computational modeling techniques for discovery
of the combination rules and pharmacodynamic characteristics of
Traditional Chinese Medicine. Eur J Pharmacol. 933:1752602022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hügle T, Boedecker J, van Laar JM,
Boedecker J and Hügle T: Applied machine learning and artificial
intelligence in rheumatology. Rheumatol Adv Pract. 4:rkaa0052020.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yousef R, Gupta G, Yousef N and Khari M: A
holistic overview of deep learning approach in medical imaging.
Multimed Syst. 28:881–914. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao Y, Chang M, Wang R, Xi IL, Chang K,
Huang RY, Vallières M, Habibollahi P, Dagli MS, Palmer M, et al:
Deep learning based on MRI for differentiation of Low- and
High-Grade in Low-stage renal cell carcinoma. J Magn Reson Imaging.
52:1542–1549. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan L, Chen M, Sun J, Jin P, Ding J, Cai
P, Chen J and Xing W: Prediction of Fuhrman grade of renal clear
cell carcinoma by multimodal MRI radiomics: A retrospective study.
Clin Radiol. 79:e273–e281. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Lih TM, Dhanasekaran SM, Mannan R,
Chen L, Cieslik M, Wu Y, Lu RJ, Clark DJ, Kołodziejczak I, et al:
Histopathologic and proteogenomic heterogeneity reveals features of
clear cell renal cell carcinoma aggressiveness. Cancer Cell.
41:139–163.e17. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nezami BG and MacLennan GT: Clear cell
renal cell carcinoma: A comprehensive review of its histopathology,
genetics, and differential diagnosis. Int J Surg Pathol.
33:265–280. 2025. View Article : Google Scholar : PubMed/NCBI
|
